Psychopharmacology 2

Overview of Drugs of Abuse

  • Types of Drugs:
    • Opioids: Morphine, Heroin, Codeine
    • Stimulants: Cocaine, Amphetamines
    • Cannabis (Main Focus)
    • Medications: Antidepressants, Anxiolytics (e.g., Diazepam)
    • Everyday substances: Alcohol, Nicotine, Caffeine

Animal Models for Drug Abuse Studies

  • Self-Administration: Animals can press a lever to self-administer a drug. Simplifies understanding abuse potential.
  • Conditioned Place Preference: Animals associate a specific area with a drug; prefer it if they like the drug, avoid it if they do not.
  • Drug Discrimination: Plants a psychological state that the animal can recognize and respond to.
  • Behavioral Tolerance: With repeated dosing, the effects of the drug diminish leading to increased dosage needs.
  • Withdrawal Effects: Observed when a dependent animal stops taking the drug, indicating physical dependence.

Cannabinoids and Abuse Models

  • Cannabinoid Self-Administration:
    • Rats show self-administration for cannabinoids, indicating potential for abuse.
    • Species-specific differences: Monkeys did not display self-administration behavior, suggesting variability in drug effects across species.
  • Conditioned Place Preference with Cannabinoids:
    • Delta-9 THC can induce both preference and aversion in animals, showing dose-dependent effects.
  • Behavioral Tolerance in Rats:
    • Chronic exposure leads to tolerance, requiring higher doses for effects.

Background on Cannabis

  • Source: Hemp plant, commonly referred to as cannabis or marijuana.
  • Effects of Smoking Cannabis:
    • Cognitive Effects: Hallucinations, depression, paranoia, cognitive dysfunction.
    • Positive Effects: Anxiety reduction, stress relief, therapeutic uses in cancer and pain management.
  • Main Psychoactive Compound: Delta-9 tetrahydrocannabinol (THC).

Cannabinoid System

  • Receptors:
    • CB1 Receptors: Predominantly in the brain, play a role in cognitive functions.
    • CB2 Receptors: Found in peripheral areas, also present in brain; involved in behavioral changes.
  • Endogenous Ligands: Anandamide and 2-arachidonoylglycerol (2-AG) interact with cannabinoid receptors.

Effects on Feeding Behavior

  • THC Increases Food Intake:
    • Administering THC results in increased eating behavior in animal models, aligning with human behavior.
  • Dose-Dependent Feeding Effect:
    • Lower doses enhance appetite, while excessively high doses may suppress it.
  • Cannabinoid Antagonists:
    • Can reduce feeding behavior; the CB1 antagonist Rimonabant (S.R. 141716A) was withdrawn due to severe side effects.

Measuring Cognitive Effects

  • Water Maze Tests:
    • Used to determine spatial learning capabilities; evaluates long-term memory impairments induced by cannabinoids.
  • Direct Infusion Studies:
    • Direct delivery of drugs into the hippocampus assesses the role of specific CB1 receptors in cognitive functioning.
  • Findings on CB1 Activation:
    • Activating CB1 receptors impairs long-term memory, revealed by cognitive performance assessments in animal models.

Therapeutic Potential of Cannabinoids

  • Appetite Stimulation: Notable for conditions requiring appetite enhancement.
  • Pain Relief: Used for chronic pain management, providing therapeutic options for patients.
  • Cognitive Enhancement: Potential to ameliorate cognitive deficits, though also known for impairing cognition in general use.
  • Motor Activity: Cannabinoids can reduce locomotor activity, relevant for treatment designs.

Conclusion

  • Animal models serve as substantial indicators of how cannabinoids affect both feeding and cognitive behaviors, showing parallels to human conditions. They highlight both the potential for abuse as well as therapeutic applications.